Here are four points:
1. Zacks presently has a $5.25 price target on EndoChoice stock.
2. EndoChoice has a 50-day moving average price of $4.78 and a 200-day moving average price of $8.50.
3. The company has a 12-month low of $3.70 and a 12-month high of $19.69.
4. The company’s market cap is $124.72 million.
More articles on GI/endoscopy:
4 GI physicians in the news — March 25, 2016
Dr. Gregory Scheible 1st in Indiana to implant Orbera intragastric balloon: 4 points
Emails show Olympus hiked up duodenoscope price 28% after CRE outbreak at UCLA: 8 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
